- ►annals.org [PDF] JT Hays, RD Hurt, NA Rigotti, R Niaura, D … - Annals of Internal Medicine, 2001 - Am Coll Physicians Participants: 784 healthy community volunteers who were mo- tivated to quit
smoking and who smoked at least 15 cigarettes per day. Intervention: The
participants received open-label, sustained- release bupropion, 300 mg/d, ... Cited by 230 - Related articles - All 8 versions
DHG PhD, MAN PhD, LH Ferry, RPK PharmD, … - Clinical Pharmacology & Therapeutics, 2001 - nature.com 1 Oregon Health Sciences University, Portland, Los Angeles; the Los Angeles
Clinical Trials, Ore, Los Angeles; the Loma Linda VA Medical Center, Loma Linda,
Calif; GlaxoWellcome Research and Development, Research Triangle Park, NC; ... Cited by 99 - Related articles - BL Direct - All 4 versions
DP Tashkin, R Kanner, W Bailey, S Buist, P … - The Lancet, 2001 - Elsevier In a double-blind, randomised, placebo-controlled trial 404 individuals with
mild or moderate COPD who smoked 15 or more cigarettes per day, were assigned
bupropion SR (150 mg twice daily) or placebo for 12 weeks. All patients ... Cited by 277 - Related articles - BL Direct - All 5 versions
KE Hayford, CA Patten, TA Rummans, DR … - The British Journal of Psychiatry, 1999 - RCP Page 1. BRITISH JOURNAL OF PSYCHIATRY (1999). 174. 173-178 Efficacy of bupropion
for smoking cessation in episode, history of alcohol ... Cited by 182 - Related articles - BL Direct - All 5 versions
- ►msal.gov.ar [PDF] RD Hurt, DPL Sachs, ED Glover, KP Offord, … - New England Journal of Medicine, 1997 - content.nejm.org Background and Methods Trials of antidepressant medications for smoking
cessation have had mixed results. We conducted a double-blind,
placebo-controlled trial of a sustained-release form of bupropion for ... Cited by 1009 - Related articles - BL Direct - All 16 versions
SM Hall, GL Humfleet, VI Reus, RF Munoz, DT … - Archives of General Psychiatry, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 96 - Related articles - BL Direct - All 4 versions
- ►msal.gov.ar [PDF] DE Jorenby, SJ Leischow, MA Nides, SI … - New England Journal of Medicine, 1999 - content.nejm.org ABSTRACT Background and Methods Use of nicotine-replace- ment therapies and the
antidepressant bupropion helps people stop smoking. We conducted a double-
blind, placebo-controlled comparison of sustained- release bupropion (244 ... Cited by 1297 - Related articles - BL Direct - All 18 versions
- ►oxfordjournals.org S Tonstad, C Farsang, G Klaene, K Lewis, A … - European heart journal, 2003 - Eur Soc Cardiology Methods Six hundred twenty-nine subjects with CVD who smoked 10 cigarettes/day
were randomised in a double-blind, multicentre study to receive bupropion SR
(150mg twice daily) or placebo for 7 weeks, with a follow-up of 52 weeks. ... Cited by 132 - Related articles - BL Direct - All 6 versions
BD Jamerson, M Nides, DE Jorenby, R Donahue … - Clinical therapeutics, 2001 - Elsevier Methods: This was a post hoc analysis of a multicenter, double-blind,
randomized, placebo-controlled clinical trial in 893 smokers. Patients were
randomly assigned to 9 weeks of treatment with placebo (n = 160), bupropion ... Cited by 61 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org RD Hurt, JE Krook, IT Croghan, CL Loprinzi, … - Journal of Clinical Oncology, 2003 - jco.ascopubs.org Purpose: To determine whether (1) tailored nicotine patch therapy that is based
on smoking rate can be carried out in a multisite oncology investigative group
practice setting, (2) long-term use of bupropion reduces the rate of ... Cited by 48 - Related articles - BL Direct - All 7 versions
